STOCK TITAN
  1. Home
  2. Sec-filings
  3. APVO
  4. [EFFECT] Aptevo Therapeutics Inc SEC Filing

[EFFECT] Aptevo Therapeutics Inc SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 18, 2025 9:00 A.M.
Form: S-1
CIK: 0001671584
Company Name: Aptevo Therapeutics Inc.
File Number: 333-288061

Source: View Original Filing on SEC EDGAR

Aptevo Therapeutics Inc

NASDAQ:APVO

View APVO Stock Overview →

APVO Rankings

#6779 Ranked by Market Cap
N/A Ranked by Dividends

APVO Latest News

Mar 19, 2026
Aptevo to Participate in March 2026 Conferences
Mar 10, 2026
Mipletamig Delivers Compelling 86% Clinical Benefit Rate and No CRS as Evaluable AML Patient Data increases by Nearly 50%
Feb 3, 2026
Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth
Jan 9, 2026
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Dec 26, 2025
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

APVO Latest SEC Filings

Mar 10, 2026
[8-K] Aptevo Therapeutics Inc. Reports Material Event
Feb 18, 2026
[8-K] Aptevo Therapeutics Inc. Reports Material Event
Feb 17, 2026
[SCHEDULE 13G/A] Aptevo Therapeutics Inc. Amended Passive Investment Disclosure
Feb 17, 2026
[SCHEDULE 13G/A] Aptevo Therapeutics Inc. Amended Passive Investment Disclosure
Feb 3, 2026
[8-K] Aptevo Therapeutics Inc. Reports Material Event

APVO Stock Data

4.21M
997.08k
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE